Financials

  • Market Capitalization 67.28 M
  • Employee 33
  • Founded 2011
  • CEO N/A
  • Website www.elicio.com
  • Headquarter Delaware, United States
  • FIGI BBG00444GM02
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.84
Price to sales ratio
5 105.86

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4110
PLRX
Pliant Therapeutics, Inc. - Common Stock
1.11 USD+0.91%-6.72%+4.72%-33.13%68.73 M USD
4120
TENX
Tenax Therapeutics, Inc. - Common Stock
1.80 USD-2.17%-21.40%-86.92%-76.16%67.36 M USD
4125
XBIT
XBiotech Inc. - Common Stock
2.19 USD-4.78%-4.78%-1.35%-27.24%66.77 M USD
4135
BOLD
Boundless Bio, Inc. - Common Stock
2.89 USD+2.85%-3.02%+16.06%+149.14%65.74 M USD

Frequently asked questions about Elicio Therapeutics, Inc. Common Stock

What is the Elicio Therapeutics, Inc. Common Stock stock price today?

The current price of Elicio Therapeutics, Inc. Common Stock (ELTX) is 2.56. Over the past 24 hours, the stock has changed by -5.19%. Follow the ELTX chart for real-time price dynamics.

What is the stock ticker of Elicio Therapeutics, Inc. Common Stock?

Elicio Therapeutics, Inc. Common Stock trades under the ticker ELTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Elicio Therapeutics, Inc. Common Stock stock going up?

ELTX has changed by -14.67% over the last week, -7.91% over the last month, and -74.40% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Elicio Therapeutics, Inc. Common Stock?

Elicio Therapeutics, Inc. Common Stock currently has a market capitalization of 67.28 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Elicio Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Elicio Therapeutics, Inc. Common Stock reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Elicio Therapeutics, Inc. Common Stock revenue for the last quarter?

Elicio Therapeutics, Inc. Common Stock reported quarterly revenue of 1 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Elicio Therapeutics, Inc. Common Stock net income for the last quarter?

Elicio Therapeutics, Inc. Common Stock reported net income of -8.22 M for the last quarter. The previous quarter showed -11.82 M, which means net income changed by +30.50%.

How many employees does Elicio Therapeutics, Inc. Common Stock have?

As of the latest available data, Elicio Therapeutics, Inc. Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.

What is Elicio Therapeutics, Inc. Common Stock EBITDA?

Elicio Therapeutics, Inc. Common Stock EBITDA is -10.27 M, and its EBITDA margin is -1.03 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Elicio Therapeutics, Inc. Common Stock stock?

You can buy Elicio Therapeutics, Inc. Common Stock (ELTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Elicio Therapeutics, Inc. Common Stock stock?

Investing in Elicio Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ELTX chart and related analysis on metatrader.com as part of your research.

News